• ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspective
Weekly Newscast
dvm360 LIVE!™
Insights
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Client Handouts
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2022 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Petriage awarded U.S. patent for telehealth technology

May 23, 2022
dvm360 Staff

This is Petriage’s second U.S. patent which will extend its AI-driven symptom analysis tool to telemedicine extending beyond pets

Petriage, a pet health technology company, announced in an organizational release1 that the U.S. Patent and Trademark Office awarded them a new patent to be issued on June 7, 2022. This patent is the company’s second, and it encompasses teletriage for all animals, including humans.

With this new patent, Petriage plans to further develop its unique AI-driven symptom analysis and triage technology to provide similar telehealth solutions for human health care. These developments include a symptom analysis tool to identify human ailments with increasing levels of urgency, virtual consultations with physicians, and automated remote monitoring.1

Petriage was designed to bring fully integrated telehealth services to veterinary practices and their clients. The company’s platform provides a way for vets to communicate with clients and deliver care to pets remotely, including a proprietary patented teletriage app in which pet parents are provided a recommendation in real-time about the need and urgency to seek medical care for their pets.

When Petriage applied for a patent on its pet evaluation and triage system, which the U.S. Patent and Trademark Office granted in February 2021 for 20 years, the company also began a long-term track to approve a patent that widens the scope and language to encompass all animals.

Joe Coury, Petriage's chief executive officer, spoke on this technological development and the extension to human health by stating, “We could envision using such learnings to provide humans with the right telehealth information at the right time.”1

Co-founders Shlomo Freiman, DVM, Casey Olives, Ph.D., and Allon Freiman developed the company’s algorithm and system analysis tool.

“Our original impetus was to empower vets like me and provide their clients with peace of mind by leveraging AI to deliver remote patient care," said Freiman. “But the 97%-plus accuracy of the AI-driven symptom analysis tool has exceeded what we initially envisioned.”

Olives added, “What has proved so exciting is that our unique machine learning model for health data is demonstrating how to marry the clinical side with the data science side, first with pets and now potentially for humans.”1

Reference

Petriage awarded U.S. patent for AI-driven telehealth technology beyond pets. News release. Petriage. May 20, 2022.

Related Content:

BusinessVirtual CareTechnology
Entrepreneurship: inventing the 5-second Doppler placement solution
Entrepreneurship: inventing the 5-second Doppler placement solution
Tailored Pet adds new supplements and treats for its summer product line
Tailored Pet adds new supplements and treats for its summer product line
Is employee ownership an answer for veterinary business succession?
Is employee ownership an answer for veterinary business succession?

Latest News

Targeted injectable therapy for canine elbow osteoarthritis

Entrepreneurship: inventing the 5-second Doppler placement solution

Tailored Pet adds new supplements and treats for its summer product line

Wellness Pet Company launches Wellness Bowl Boosters Freshly

View More Latest News